Martin Philpott
Queen Mary University of London(GB)Nuffield Orthopaedic Centre(GB)University of Oxford(GB)Oxford BioMedica (United Kingdom)(GB)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Ubiquitin and proteasome pathways
Most-Cited Works
- → Selective inhibition of BET bromodomains(2010)4,234 cited
- → RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain(2013)477 cited
- → Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains(2014)282 cited
- → PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains(2013)245 cited
- → Dietary cancer and prevention using antimutagens(2004)243 cited
- → Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy(2015)225 cited